Why is Medico Remedies falling/rising?

As of 04-Jul, Medico Remedies Ltd is currently priced at Rs 42.50, reflecting an increase of Rs 1.11 or 2.68%. The stock has shown a positive performance today, outperforming its sector by 2.17% and has gained consecutively over the last two days, accumulating a total return of 4.63%. However, despite this recent uptick, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a longer-term downward trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 91.92% compared to the 5-day average. While the company has demonstrated strong financial metrics, such as a low Debt to EBITDA ratio and impressive quarterly profit growth, concerns about its expensive valuation and decreasing promoter confidence—evidenced by a 3.04% reduction in their stake—may weigh on investor sentiment.
In the broader market context, Medico Remedies has outperformed the benchmark Sensex in the short term, with a 1-week return of +6.06% compared to the Sensex's -0.74%. However, over the longer term, the stock has underperformed, with a year-to-date decline of 21.92% against the Sensex's gain of 6.77%. This disparity highlights the stock's volatility and the challenges it faces despite recent positive performance. The mixed signals from both the company's financial health and market performance suggest that while there are some positive indicators, the overall outlook remains cautious due to valuation concerns and reduced promoter confidence.